Otolaryngology · Akron, OH
NPI
1487644100
Since 2005
Specialty
Otolaryngology
Code 207Y00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
570 White Pond Dr Ste 100
Akron, OH, 44320
Phone (330) 315-5051
Medicare paid, 2024
$102K
4,634 services
Medicare patients, 2024
439
Average age 74
Drug cost, 2024
$352K
3,154 prescriptions
Company payments, 2025
$52.68
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kurt C Garren was code 95165 (treatment - miscellaneous), 1,702 times for 43 patients. In total Kurt C Garren billed 4,634 services in 74 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 1,702 | 43 | $9.32 | $16K |
| 95004 Test - Miscellaneous | Office | 1,292 | 34 | $2.29 | $2,956 |
| 99213 Office E&M - Established | Office | 340 | 217 | $55.04 | $19K |
| 95115 Treatment - Miscellaneous | Office | 241 | 22 | $6.59 | $1,588 |
| 95117 Treatment - Miscellaneous | Office | 223 | 14 | $7.35 | $1,639 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 195 | 141 | $12.30 | $2,398 |
| 99214 Office E&M - Established | Office | 151 | 121 | $75.78 | $11K |
| 69210 Other Organ Systems | Office | 132 | 88 | $25.56 | $3,374 |
| 99203 Office E&M - New | Office | 104 | 104 | $57.38 | $5,968 |
| 99212 Office E&M - Established | Office | 33 | 31 | $37.76 | $1,246 |
| 99204 Office E&M - New | Office | 31 | 31 | $93.11 | $2,886 |
| 31575 Other Organ Systems | Office | 29 | 26 | $81.81 | $2,373 |
| 31231 Nasal/Sinus Endoscopy | Office | 14 | 14 | $117.95 | $1,651 |
| 69433 Other Organ Systems | Office | 11 | 11 | $164.32 | $1,807 |
By year: 2022 $131K for 6,816 services; 2023 $147K for 4,791 services; 2024 $102K for 4,634 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kurt C Garren prescribed most often to Medicare patients was Fluticasone Propionate, with 532 prescriptions and refills. In total Kurt C Garren wrote 3,154 Medicare prescriptions that cost $352K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 532 | 648 | 184 | $4,266 |
| Ipratropium Bromide Generic | 262 | 340 | 89 | $6,740 |
| Levocetirizine Dihydrochloride Generic | 243 | 362 | 49 | $3,097 |
| Omeprazole Generic | 222 | 321 | 47 | $2,050 |
| Azelastine Hcl Generic | 200 | 280 | 82 | $2,947 |
| Montelukast Sodium Generic | 165 | 208 | 33 | $863 |
| Pantoprazole Sodium Generic | 128 | 181 | 31 | $1,346 |
| Methylprednisolone Generic | 111 | 111 | 101 | $644 |
| Mupirocin Generic | 88 | 91 | 69 | $521 |
| Famotidine Generic | 88 | 116 | 22 | $656 |
| Ofloxacin Generic | 75 | 77 | 52 | $3,411 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 71 | 73 | 54 | $7,251 |
| Xhance Fluticasone Propionate | 69 | 85 | 14 | $48K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 68 | 68 | 55 | $268 |
| Prednisone Generic | 67 | 67 | 64 | $248 |
Brand drugs: - claims; generic drugs: 2,887 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kurt C Garren $52.68 ($52.68 in general payments such as food, travel and fees) from 1 company. The largest payer was Integra LifeSciences Corporation with $52.68.
| Company | Payments | Amount |
|---|---|---|
| Integra LifeSciences Corporation IART | 1 | $52.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.